To view the PDF file, sign up for a MySharenet subscription.
Back to DCP SENS
DIS-CHEM:  3,800   +143 (+3.91%)  20/02/2026 19:14

DIS-CHEM PHARMACIES LIMITED - Trading Update For The Period 1 September 2025 To 16 February 2026

Release Date: 20/02/2026 07:05
Code(s): DCP     PDF:  
Wrap Text
Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE share code: DCP
ISIN: ZAE000227831
("Dis-Chem" or "the Group")


TRADING UPDATE FOR THE PERIOD 1 SEPTEMBER 2025 TO 16 FEBRUARY 2026 ' Group revenue increased by 10.1% ' Retail revenue increased by 9.5% ' Wholesale revenue increased by 15.7%
' External wholesale revenue increased by 13.7%
For the 24-week period from 1 September 2025 to 16 February 2026 ("the period"), Dis-Chem recorded Group revenue growth of 10.1% compared to the corresponding period in the prior year. Chief Executive Rui Morais
"We experienced a solid trading performance during the period, notably on the back of the launch of our reimagined loyalty programme, Better Rewards, which launched on 21 October 2025. By applying technology, data and deep customer insights, the X, bigly labs team continues to challenge the status quo by further evolving the Better Rewards programme.
One of our key objectives is to increase the average level of discount by driving the increase of boost penetration, a key design element of the programme, as well as identifying new funding channels across our ecosystem to further invest into the programme, ensuring that we have the best-value and most representative healthcare retail offering in South Africa. Our ecosystem extends beyond the integrated healthcare ecosystem we're building, to strategic partnerships like Capitec, where the Capitec boost is driving shared value for both brands and our shared customers.
In the 17 weeks since launch, we have returned R410 million in savings directly to customers; funds that our customers can reinvest directly into their health, making healthcare more accessible, more affordable and more meaningful.
The market share gains we've seen have been particularly pleasing and stands as a proof point of innovation in action." Retail
Retail revenue for the 24 weeks increased by 9.5% over the period compared to the corresponding period, with volume growth of 5.0%. Like-for-like retail revenue increased by 5.7%.
Retail revenue for the 17 weeks under the Better Rewards programme increased by 10.4% compared to the corresponding period, with volume growth of 5.2%.
Under the Better Rewards programme, pharmacy revenue grew by 13.7% driven by increasing pharmacy boost engagement and high demand for GLP-1 drugs.
Revenue growth of participating Better Rewards brands increased by 19.4% with volume growth of 20.9%. The consistency of an always-on, health-relevant, lowest price basket is driving increased shopping frequency. Non-participating Better Rewards brands are benefiting from the halo effect of the increase in shopper trips.
The number of new shoppers who had not engaged with the Dis-Chem brand in the 12 months prior to the launch of Better Rewards, increased by 550,000 shoppers.
As reported by NielsenIQ for the 12 weeks ended 25 January 2026, for Dis-Chem's core retail categories, Dis-Chem achieved volume growth of 8.0% against a market volume growth of 1.3%, increasing its market share across all core categories by 0.8 percentage points.
The Group operates 355 retail stores, comprising 313 Dis-Chem Pharmacy stores and 42 Dis-Chem Baby City stores. Wholesale
Wholesale revenue increased by 15.7% during the period compared to the corresponding period. Sales to the Group's own retail stores increased by 16.2%
Revenue from external customers increased by 13.7%, with The Local Choice (TLC) revenue growing by 14.2% and independent pharmacy revenue increasing by 13.4%.
The Group has 281 TLC franchise stores at period-end, up from 230 at the end of the corresponding period. Other information
The financial information contained in this trading update has not been reviewed or reported on by the Group's independent auditors, Forvis Mazars.
Dis-Chem's results for the year ended 28 February 2026 are expected to be released on SENS on Friday, 29 May 2026, at approximately 07:05.
For further information, please contact the Group's Investor Relations at investorrelations@dischem.co.za Midrand 20 February 2026 Sponsor The Standard Bank of South Africa Limited Date: 20-02-2026 07:05:00
Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.